SFOSF Stock Shanghai Fosun Pharmaceutical Group (SFOSF, $2.78) was a top loser this quarter, falling -20.57%

GET DAILY SIGNALS

Get AI intraday signals

SFOSF - Shanghai Fosun Pharmaceutical Group Co Ltd

Loading...

Price: $2.78

Daily change: +$0.01 (+0.36%)

Daily volume: 100

3-month price change: -$0.72 (-20.57%)

Capitalization: $9.4B

Industry: Pharmaceuticals: Generic

Shanghai Fosun Pharmaceutical Group (SFOSF, $2.78) was a top loser over the last three months, falling -2 to $2.78 per share. A.I.dvisor analyzed 214 stocks in the Pharmaceuticals: Generic Industry for the 3-month period ending December 29, 2025, and found that of them () exhibited an Uptrend while of them () demonstrated a Downtrend.

SFOSF in downward trend: price dove below 50-day moving average on December 19, 2025

SFOSF moved below its 50-day moving average on December 19, 2025 date and that indicates a change from an upward trend to a downward trend. In of 29 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 10-day moving average for SFOSF crossed bearishly below the 50-day moving average on December 19, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where SFOSF's RSI Indicator exited the oversold zone, of 42 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on January 06, 2026. You may want to consider a long position or call options on SFOSF as a result. In of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SFOSF just turned positive on January 09, 2026. Looking at past instances where SFOSF's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.078) is normal, around the industry mean (38.468). P/E Ratio (15.634) is within average values for comparable stocks, (75.912). SFOSF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.031). Dividend Yield (0.016) settles around the average of (0.029) among similar stocks. P/S Ratio (1.296) is also within normal values, averaging (68.131).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SFOSF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SFOSF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.